Jonathan Serody

21PUBLICATIONS
102CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 17, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.

|Sep 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults.

Felicia Cao, Yueling Xiu, Michael Mohnasky

|Aug 12, 2025
A Tacrolimus Population Pharmacokinetic Model for Adult Allogeneic Hematopoietic Cell Transplant Recipients Provides Clinical Opportunities for Precision Dosing.

Tyler C Dunlap, Jing Zhu, Daniel L Weiner

|Jul 21, 2025
A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD.

Danny W Bruce, Sonia J Laurie, Yan Xing

|Feb 07, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

Kim A Reiss, Mathew G Angelos, E Claire Dees

|Jul 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults.

Felicia Cao, Yueling Xiu, Michael Mohnasky

Pageof 4

Frequent Collaborators

5 joint publications

Benjamin Vincent

4 joint publications

Sonia J Laurie

4 joint publications

Natalie Grover

3 joint publications

Charles M Perou